News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Vivo Capital VIII, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/23/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 758,620 shares
@ $7.25, valued at
$5.5M
|
|
| 09/08/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 600,000 shares
@ $3.6, valued at
$2.2M
|
|
| 08/16/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 1,123,021 shares
@ $2.98, valued at
$3.3M
Bought 1,218 shares
@ $2.99, valued at
$3.6k
Bought 1,500,000 shares
@ $2.42, valued at
$3.6M
Bought 1,500,000 options to buy
@ $0.0001, valued at
$150 |
|
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Converted 1,933,185 shares
@ $0
Converted 266,948 shares
@ $0
Bought 103,372 shares
@ $17, valued at
$1.8M
Bought 14,275 shares
@ $17, valued at
$242.7k
Bought 357,353 shares
@ $17, valued at
$6.1M
Converted 713,203 preferred shares
@ $0
Converted 98,484 preferred shares
@ $0
Converted 364,138 preferred shares
@ $0
Converted 50,282 preferred shares
@ $0 |
|
| 10/20/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Converted 1,885,611 shares
@ $0
Converted 523,726 shares
@ $0
Converted 224,054 shares
@ $0
Converted 260,380 shares
@ $0
Converted 72,320 shares
@ $0
Converted 30,939 shares
@ $0
Bought 483,267 shares
@ $15, valued at
$7.2M
Bought 66,733 shares
@ $15, valued at
$1M
Converted 1,885,611 preferred shares
@ $0
Converted 260,380 preferred shares
@ $0
Converted 523,726 preferred shares
@ $0 |
|
| 04/17/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 189,625 shares
@ $15.5, valued at
$2.9M
Sold 26,185 shares
@ $15.5, valued at
$405.9k
Sold 26,527 shares
@ $15.2, valued at
$403.2k
Sold 3,663 shares
@ $15.2, valued at
$55.7k
Sold 74,333 shares
@ $15.4, valued at
$1.1M
Sold 10,265 shares
@ $15.4, valued at
$158.1k
|
|
| 04/07/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 263,600 shares
@ $13.8, valued at
$3.6M
Sold 36,400 shares
@ $13.8, valued at
$502.3k
Sold 5,373 shares
@ $14.2, valued at
$76.3k
Sold 742 shares
@ $14.2, valued at
$10.5k
|
|
| 03/11/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 347 shares
@ $19.5, valued at
$6.8k
Sold 48 shares
@ $19.5, valued at
$936
Sold 133 shares
@ $19.5, valued at
$2.6k
|
|
| 02/11/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 1,134 shares
@ $22, valued at
$24.9k
Sold 157 shares
@ $22, valued at
$3.5k
Sold 4,614 shares
@ $22, valued at
$101.5k
Sold 1,451 shares
@ $21.4, valued at
$31.1k
Sold 200 shares
@ $21.4, valued at
$4.3k
Sold 5,904 shares
@ $21.4, valued at
$126.3k
|
|
| 02/06/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 2,584 shares
@ $22.8, valued at
$58.9k
Sold 357 shares
@ $22.8, valued at
$8.1k
Sold 10,519 shares
@ $22.8, valued at
$239.8k
|
|
| 01/31/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 2,673 shares
@ $22.2, valued at
$59.3k
Sold 369 shares
@ $22.2, valued at
$8.2k
Sold 10,878 shares
@ $22.2, valued at
$241.5k
Sold 1,459 shares
@ $22.1, valued at
$32.2k
Sold 201 shares
@ $22.1, valued at
$4.4k
Sold 5,940 shares
@ $22.1, valued at
$131.3k
Sold 1,037 shares
@ $21.7, valued at
$22.5k
Sold 143 shares
@ $21.7, valued at
$3.1k
Sold 4,220 shares
@ $21.7, valued at
$91.6k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2019 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 292,609 shares
@ $22.25, valued at
$6.5M
Sold 40,407 shares
@ $22.25, valued at
$899.1k
Sold 83,984 shares
@ $22.25, valued at
$1.9M
|
|
| 07/20/2018 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Converted 2,560,613 shares
@ $0
Converted 353,590 shares
@ $0
Converted 413,040 shares
@ $0
Converted 57,035 shares
@ $0
Bought 51,686 shares
@ $17, valued at
$878.7k
Bought 7,137 shares
@ $17, valued at
$121.3k
Bought 141,177 shares
@ $17, valued at
$2.4M
Bought 153,180 shares
@ $20.73, valued at
$3.2M
Converted 8,424,416 preferred shares
@ $0
Converted 1,163,311 preferred shares
@ $0
Converted 1,358,903 preferred shares
@ $0 |
|
| 03/09/2018 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on BioPharmX Corp|
Txns:
| Sold 2,000,000 shares
@ $0.36, valued at
$720k
|
|
| 01/31/2018 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on BioPharmX Corp|
Txns:
| Converted 4,328,571 shares
@ $0
Converted 1,515 convertible preferred
@ $0 |
|
| 01/29/2018 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Menlo Therapeutics, Inc.|
Txns:
| Bought 258,432 shares
@ $17, valued at
$4.4M
Bought 35,686 shares
@ $17, valued at
$606.7k
Converted 2,348,550 shares
@ $0
Converted 324,306 shares
@ $0
Converted 917,559 shares
@ $0
Converted 126,703 shares
@ $0
Converted 6,335,215 preferred shares
@ $0
Converted 874,817 preferred shares
@ $0
Converted 2,475,118 preferred shares
@ $0
Converted 341,784 preferred shares
@ $0 |
|
| 11/13/2017 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on BioPharmX Corp|
Txns:
| Sold 296,394 shares
@ $0.2, valued at
$59.3k
|
|
| 09/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|